Skip to main content
Premium Trial:

Request an Annual Quote

USPTO Publishes Three RNAi-Related Patent Applications: Jun 8, 2006

Premium

Title: Therapeutic RNAi Agents for Treating Psoriasis

Number: 20060115455

Filed: Oct. 21, 2005

Lead Inventor: Ken Reed, Benitec

According to the patent application's abstract, the invention "provides compositions and methods suitable for delivering RNAi agents against genetic targets in skin tissues so as to treat psoriasis."


Title: Therapeutic RNAi Agents for Treating Restenosis

Number: 20060115454

Filed: Oct. 14, 2005

Lead Inventor: Linda Couto, Benitec

According to the patent application's abstract, the invention "provides compositions and methods suitable for delivering RNAi agents against genetic targets in vascular and adjacent tissue in vivo so as to treat restenosis."


Title: Apparatus and System Having Dry Gene-Silencing Compositions

Number: 20060115461

Filed: Nov. 18, 2005

Lead Inventor: Barbara Robertson, Dharmacon

The patent application, its abstract states, covers "a reverse-transfection apparatus … for introducing siRNA into a cell to effect gene silencing. Such an apparatus can include a well plate having a well configured for transfecting cells. The well can include a substantially dry gene-silencing composition that has at least a first siRNA which silences a first target gene. The gene-silencing composition can be configured such that the at least first siRNA is capable of being solubilized or suspended in an aqueous medium in an amount sufficient for transfecting cells in the well. Additionally, the at least first siRNA can include a modification or a conjugate. The reverse-transfection apparatus can be provided as a kit or system that additionally includes cells, polynucleotide carriers, reverse transfection reagents, and the like."

The Scan

Missed Early Cases

A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports.

Limited Journal Editor Diversity

A survey finds low diversity among scientific and medical journal editors, according to The Scientist.

How Much of a Threat?

Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned.

PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs

In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.